Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan

por Kagawa, Y., Shinozaki, E., Okude, R., Tone, T., Kunitomi, Y., Nakashima, M.
Publicado 2023

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

por Shimozaki, K., Nakayama, I., Takahari, D., Kamiimabeppu, D., Osumi, H., Wakatsuki, T., Ooki, A., Ogura, M., Shinozaki, E., Chin, K., Yamaguchi, K.
Publicado 2021

Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

por Nakayama, I., Takahari, D., Chin, K., Wakatsuki, T., Takamatsu, M., Yamamoto, N., Ogura, M., Ooki, A., Fukuda, K., Osumi, H., Fukuoka, S., Shinozaki, E., Yamaguchi, K.
Publicado 2023

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

por Yoshino, T., Cleary, J. M., Van Cutsem, E., Mayer, R. J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero, A., Yamaguchi, K., Peeters, M., Muro, K., Zaniboni, A., Sugimoto, N., Shimada, Y., Tsuji, Y., Hochster, H. S., Moriwaki, T., Tran, B., Esaki, T., Hamada, C., Tanase, T., Benedetti, F., Makris, L., Yamashita, F., Lenz, H.-J.
Publicado 2020